Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
Non-ampullary duodenal adenocarcinoma: Factors important for relapse and survival
Journal of Surgical Oncology, 06/23/09
Struck A et al. - In a study to explore treatment outcomes and the impact of radical resection, node-status, and adjuvant therapy, it appears that nodal-status and overall pathological-stage significantly affect prognosis for pts with duodenal adenocarcinoma (DA), while resection-status and adjuvant therapy may not. The role of adjuvant therapy requires prospective trials for elucidation.
Methods- In the past 17 years, 30 pts presented with resectable DA.
- Data on the aforementioned variables were acquired then analyzed for impact on recurrence and survival.
- Overall-survival rates at 1, 2, and 3 yrs were 70.0%, 53.3%, and 33.3% respectively.
- Recurrence-free survival rates at 1, 2, and 3 yrs were 53.3%, 30.0%, and 26.7%.
- Overall-survival rates for pts with node-positive disease at 1, 2, and 3 yrs were 68.8%, 43.8%, 12.5%, and for node-negative 70%, 60%, 60%.
- Recurrence-free survival in node-positive disease at 1, 2, 3 yrs was 50%, 12.5%, 12.5%, and for node negative 50%, 50%, and 40%.
- Median survival from diagnosis was 27.5 mos (0.5-226.7 mos).
- Significant predictors of recurrence and survival were nodal-status and AJCC stage.
- Adjuvant therapy, surgical-type, pathological tumor-stage, and surgical margins were not significant.
Today in Hepatobiliary/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Pancreaticojejunostomy with a Low Rate of Anastomotic Failure-Related Complications
Journal of the American College of Surgeons, 10/30/09
Appropriate management of common bile duct stones: A RAND Corporation/UCLA Appropriateness Method statistical analysis
Surgical Endoscopy, 11/19/09
Day case laparoscopic cholecystectomy is feasible
Irish Journal of Medical Science, 11/02/09
Today in Surgical Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Localized resection for colon cancer
Surgical Oncology, 11/04/09
Quality of surgery for rectal carcinoma: comparison between open and laparoscopic approaches
The American Journal of Surgery, 11/03/09
Original contribution: surgeon recommendations and receipt of mastectomy for treatment of breast cancer
JAMA, 10/28/09
Sponsor
Article Search
Sponsor


See Latest Articles


